Physician profile

Biren M Patel

Urology · Casa Grande, AZ

NPI 1851336184

$6,679.73

in general payments reported to CMS, 2019-2025

50 companies · $1,133 in 2025

The $1,133 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,766.14
Education$26.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Neotract INC. $1,243.42 2019
Janssen Biotech, INC. $567.55 2019-2025 Erleada
Myriad Genetic Laboratories, INC. $531.89 2020-2024 Prolaris
Pfizer INC. $449.29 2019-2025
Boston Scientific Corporation $401.31 2019-2025 Solyx Sis System, Lithoclast, Lithovue
Urogen Pharma, INC. $317.10 2020-2025 Jelmyto
Astellas Pharma US INC $304.63 2019-2025 Xtandi
Blue Earth Diagnostics $248.02 2019-2025 Posluma
Femselect INC. $232.46 2025 Enplace
Teleflex LLC $201.37 2023-2025 Urolift, Barrigel
Sumitomo Pharma America, INC. $142.25 2024-2025 Orgovyx, Gemtesa
Coloplast Corp $131.91 2019-2024 Saffron
Myovant Sciences INC. $129.34 2021-2022
Bayer Healthcare Pharmaceuticals INC. $113.26 2019-2025
Antares Pharma, INC. $102.70 2019-2025 Xyosted
Show all 50 companies
CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $94.89 2020-2025 Lynparza
Procept Biorobotics Corporation $94.59 2024-2025 Aquabeam System
Axonics, INC. $92.24 2021-2024 Axonics
Medtronic, INC. $91.00 2021-2022
Novartis Pharmaceuticals Corporation $88.38 2024-2025
Abbvie INC. $76.48 2021-2024
Endo USA, INC. $76.39 2024-2025 Xiaflex, Aveed
Karl Storz Endoscopy-America $75.78 2021
180 Medical, INC. $74.00 2024-2025 Gentlecath Glide
Ferring Pharmaceuticals INC. $61.58 2024-2025 Adstiladrin
Rochester Medical Corporation $57.94 2021-2022
Tolmar Pharmaceuticals, INC. $57.32 2020-2022
Sun Pharmaceutical Industries INC. $56.99 2019-2022
Laborie Medical Technologies Corp. $52.25 2024 Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology
Endo Pharmaceuticals INC. $50.04 2020-2021
Innovation Technologies INC $40.06 2023-2024 Irrisept
Accord Healthcare, INC. $34.42 2022-2024
Progenics Pharmaceuticals, INC. $34.18 2022-2023 Pylarify
Baxter Healthcare $31.88 2025 Floseal
Caldera Medical, INC $31.69 2021
Novo Nordisk INC $31.36 2025 Rivfloza
Olympus America INC. $27.89 2021-2025 Itind System
Smith+Nephew, INC. $24.20 2020-2024 Stravix Pl
Immunitybio, INC. $22.20 2024
Merck Sharp & Dohme LLC $21.53 2021
Calyxo, INC. $21.43 2025 Cvac Aspiration System
Convatec INC. $19.91 2023
Foundation Medicine, INC. $19.48 2020
C. R. Bard, INC. & Subsidiaries $16.76 2025 Bard Urinary Drainage Bag
Agiliti Surgical, INC. $16.47 2025 Sonablate Hifu
Genzyme Corporation $15.90 2020
Tolmar, INC. $14.70 2024
Therapeuticsmd, INC. $14.69 2019
Dentsply Ih INC. $13.81 2019
Zyla Life Sciences, INC. $10.80 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Biren M Patel

$6,679.73

in general payments reported 2019-2025

Years
2019-2025
Top company
Neotract INC.
Context
The $1,133 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/128783/biren-m-patel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.